Table III.
Number of patients | TNC expression (n) | ||||
---|---|---|---|---|---|
Characteristic | Total, 115 | Low | High | High expression rate, % | P-value |
Age, years | 0.703 | ||||
<50 | 51 | 18 | 33 | 64.7 | |
>50 | 64 | 25 | 39 | 60.9 | |
Sex | |||||
Male | 78 | 29 | 47 | 60.3 | 0.842 |
Female | 37 | 14 | 25 | 67.6 | |
T stage | 0.001a | ||||
T1-T2 | 39 | 23 | 16 | 41.0 | |
T3-T4 | 76 | 20 | 56 | 73.7 | |
N stage | <0.0001b | ||||
N0-N1 | 52 | 32 | 20 | 38.5 | |
N2-N3 | 63 | 11 | 52 | 82.5 |
P<0.01
P<0.001. ‘−’ and ‘+’ were classified as low TNC expression, while ‘++’ and ‘+++’ were classified as high TNC expression. TNC, tenascin-C; NPC, nasopharyngeal carcinoma.